Early human trial data shows that a third dose of either Moderna's current COVID-19 shot or an experimental new vaccine candidate increases immunity against variants of the virus behind COVID-19 first found in Brazil and South Africa, the company announced on Wednesday.
from CBC | Health News https://ift.tt/3th8ILW
Aucun commentaire:
Enregistrer un commentaire